Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.

Blauvelt A, Reich K, Tsai TF, Tyring S, Vanaclocha F, Kingo K, Ziv M, Pinter A, Vender R, Hugot S, You R, Milutinovic M, Thaçi D.

J Am Acad Dermatol. 2016 Sep 20. pii: S0190-9622(16)30624-7. doi: 10.1016/j.jaad.2016.08.008. [Epub ahead of print]

PMID:
27663079
2.

Biosimilars for Psoriasis: Clinical Studies to Determine Similarity.

Blauvelt A, Puig L, Chimenti S, Vender R, Rajagopalan M, Romiti R, Skov L, Zachariae C, Young H, Prens E, Cohen A, van der Walt J, Wu JJ.

Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15067. [Epub ahead of print] Review.

PMID:
27639072
3.

Review of Systemic Treatment Options for Adult Atopic Dermatitis.

Gooderham M, Lynde CW, Papp K, Bourcier M, Guenther L, Gulliver W, Hong CH, Poulin Y, Sussman G, Vender R.

J Cutan Med Surg. 2016 Sep 15. pii: 1203475416670364. [Epub ahead of print] Review.

PMID:
27635033
4.

Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis.

Griffiths CE, Vender R, Sofen H, Kircik L, Tan H, Rottinghaus ST, Bachinsky M, Mallbris L, Mamolo C.

J Eur Acad Dermatol Venereol. 2016 Sep 7. doi: 10.1111/jdv.13808. [Epub ahead of print]

PMID:
27600367
5.
6.

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009.

Canadian Psoriasis Guidelines Addendum Committee.

J Cutan Med Surg. 2016 Sep;20(5):375-431. doi: 10.1177/1203475416655705. Epub 2016 Jul 15. Review. No abstract available.

7.

Reply.

Ranasinghe I, Parzynski CS, Searfoss R, Montague J, Lin Z, Allen J, Vender R, Bhat K, Ross JS, Bernheim S, Krumholz HM, Drye E.

Gastroenterology. 2016 May;150(5):1249-51. doi: 10.1053/j.gastro.2016.03.031. Epub 2016 Mar 26. No abstract available.

PMID:
27025674
8.

Psoronychomycosis: A New Term for an Old Problem.

Vender R, Vender R.

J Cutan Med Surg. 2016 May;20(3):279-80. doi: 10.1177/1203475416640796. Epub 2016 Mar 18.

PMID:
26992422
9.

Acral Hemorrhagic Darier's Disease: A Case Report.

Vender R, Vender R.

J Cutan Med Surg. 2016 Sep;20(5):478-80. doi: 10.1177/1203475416640993. Epub 2016 Mar 18.

PMID:
26992421
10.

Characteristics of Resting Metabolic Rate in Critically Ill, Mechanically Ventilated Adults With Cystic Fibrosis.

Frankenfield DC, Ashcraft CM, Drasher TL, Reid EK, Vender RL.

JPEN J Parenter Enteral Nutr. 2015 Nov 5. pii: 0148607115617152. [Epub ahead of print]

PMID:
26542193
11.

Biosimilars for psoriasis: preclinical analytical assessment to determine similarity.

Blauvelt A, Cohen AD, Puig L, Vender R, van der Walt J, Wu JJ.

Br J Dermatol. 2016 Feb;174(2):282-6. doi: 10.1111/bjd.14267. Epub 2015 Dec 30. Review.

PMID:
26522054
12.

Differences in Colonoscopy Quality Among Facilities: Development of a Post-Colonoscopy Risk-Standardized Rate of Unplanned Hospital Visits.

Ranasinghe I, Parzynski CS, Searfoss R, Montague J, Lin Z, Allen J, Vender R, Bhat K, Ross JS, Bernheim S, Krumholz HM, Drye EE.

Gastroenterology. 2016 Jan;150(1):103-13. doi: 10.1053/j.gastro.2015.09.009. Epub 2015 Sep 25.

PMID:
26404952
13.

Biodiversity inventories in high gear: DNA barcoding facilitates a rapid biotic survey of a temperate nature reserve.

Telfer AC, Young MR, Quinn J, Perez K, Sobel CN, Sones JE, Levesque-Beaudin V, Derbyshire R, Fernandez-Triana J, Rougerie R, Thevanayagam A, Boskovic A, Borisenko AV, Cadel A, Brown A, Pages A, Castillo AH, Nicolai A, Glenn Mockford BM, Bukowski B, Wilson B, Trojahn B, Lacroix CA, Brimblecombe C, Hay C, Ho C, Steinke C, Warne CP, Garrido Cortes C, Engelking D, Wright D, Lijtmaer DA, Gascoigne D, Hernandez Martich D, Morningstar D, Neumann D, Steinke D, Marco DeBruin DD, Dobias D, Sears E, Richard E, Damstra E, Zakharov EV, Laberge F, Collins GE, Blagoev GA, Grainge G, Ansell G, Meredith G, Hogg I, McKeown J, Topan J, Bracey J, Guenther J, Sills-Gilligan J, Addesi J, Persi J, Layton KK, D'Souza K, Dorji K, Grundy K, Nghidinwa K, Ronnenberg K, Lee KM, Xie L, Lu L, Penev L, Gonzalez M, Rosati ME, Kekkonen M, Kuzmina M, Iskandar M, Mutanen M, Fatahi M, Pentinsaari M, Bauman M, Nikolova N, Ivanova NV, Jones N, Weerasuriya N, Monkhouse N, Lavinia PD, Jannetta P, Hanisch PE, McMullin RT, Ojeda Flores R, Mouttet R, Vender R, Labbee RN, Forsyth R, Lauder R, Dickson R, Kroft R, Miller SE, MacDonald S, Panthi S, Pedersen S, Sobek-Swant S, Naik S, Lipinskaya T, Eagalle T, Decaëns T, Kosuth T, Braukmann T, Woodcock T, Roslin T, Zammit T, Campbell V, Dinca V, Peneva V, Hebert PD, deWaard JR.

Biodivers Data J. 2015 Aug 30;(3):e6313. doi: 10.3897/BDJ.3.e6313. eCollection 2015.

14.

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.

Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators.

Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.

PMID:
26072109
15.

Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines.

Guenther LC, Barber K, Searles GE, Lynde CW, Janiszewski P, Ashkenas J; Canadian Non-melanoma Skin Cancer Guidelines Committee.

J Cutan Med Surg. 2015 May-Jun;19(3):205-15. doi: 10.1177/1203475415588652. Epub 2015 May 27. Erratum in: J Cutan Med Surg. 2015 Nov-Dec;19(6):604.

PMID:
26016676
16.

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.

Zloty D, Guenther LC, Sapijaszko M, Barber K, Claveau J, Adamek T, Ashkenas J; Canadian Non-melanoma Skin Cancer Guidelines Committee.

J Cutan Med Surg. 2015 May-Jun;19(3):239-48. doi: 10.1177/1203475415586664. Epub 2015 May 18. Erratum in: J Cutan Med Surg. 2015 Nov-Dec;19(6):604. J Cutan Med Surg. 2015 Nov-Dec;19(6):604.

PMID:
25986316
17.

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group.

N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17.

18.

Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.

Poulin Y, Lynde CW, Barber K, Vender R, Claveau J, Bourcier M, Ashkenas J; Canadian non-Melanoma Skin Cancer Guidelines Committee.

J Cutan Med Surg. 2015 May-Jun;19(3):227-38. doi: 10.1177/1203475415583414. Epub 2015 Apr 29. Erratum in: J Cutan Med Surg. 2015 Nov-Dec;19(6):604. J Cutan Med Surg. 2015 Nov-Dec;19(6):604.

PMID:
25926621
19.

Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma.

Sapijaszko M, Zloty D, Bourcier M, Poulin Y, Janiszewski P, Ashkenas J; Canadian Non-melanoma Skin Cancer Guidelines Committee.

J Cutan Med Surg. 2015 May-Jun;19(3):249-59. doi: 10.1177/1203475415582318. Epub 2015 Apr 28. Erratum in: J Cutan Med Surg. 2015 Nov-Dec;19(6):604. J Cutan Med Surg. 2015 Nov-Dec;19(6):604.

PMID:
25922470
20.

Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.

Gulliver W, Lynde C, Dutz JP, Vender RB, Yeung J, Bourcier M, Dion PL, Hong CH, Searles G, Poulin Y.

J Cutan Med Surg. 2015 Jan-Feb;19(1):22-7. doi: 10.2310/7750.2014.13151. Epub 2015 Jan 1.

PMID:
25775659
Items per page

Supplemental Content

Loading ...
Write to the Help Desk